Waldenström Macroglobulinemia: Review of Pathogenesis and Management.

about

Rare transformation to double hit lymphoma in Waldenstrom's macroglobulinemia.Recurrent chylothorax: a clinical mystery.

P2860

Q38644775-EE923152-F8DD-4A5F-840B-0616E069C70E Q42650210-9EE47029-842C-41C7-82C2-A50FDC88D394

P2860

Waldenström Macroglobulinemia: Review of Pathogenesis and Management.

Item

http://www.wikidata.org/entity/Q39214071

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Waldenström Macroglobulinemia: Review of Pathogenesis and Management.

@en

Waldenström Macroglobulinemia: Review of Pathogenesis and Management.

@nl

type

Item

label

Waldenström Macroglobulinemia: Review of Pathogenesis and Management.

@en

Waldenström Macroglobulinemia: Review of Pathogenesis and Management.

@nl

prefLabel

Waldenström Macroglobulinemia: Review of Pathogenesis and Management.

@en

Waldenström Macroglobulinemia: Review of Pathogenesis and Management.

@nl

P1476

Waldenström Macroglobulinemia: Review of Pathogenesis and Management.

@en

P2093

Ali McBride

http://www.w3.org/2001/XMLSchema#string

Ariel C Johnson

http://www.w3.org/2001/XMLSchema#string

Ling Zhang

http://www.w3.org/2001/XMLSchema#string

Onyemaechi N Okolo

http://www.w3.org/2001/XMLSchema#string

Rachid C Baz

http://www.w3.org/2001/XMLSchema#string

Seongseok Yun

http://www.w3.org/2001/XMLSchema#string

Stacy J Arnold

http://www.w3.org/2001/XMLSchema#string

P2860

Trafficking of the HIV coreceptor CXCR4. Role of arrestins and identification of residues in the c-terminal tail that mediate receptor internalization

A phase II trial of the oral mTOR inhibitor everolimus in relapsed aggressive lymphoma

Initial genome sequencing and analysis of multiple myeloma

MYD88 L265P somatic mutation in Waldenström's macroglobulinemia.

Ibrutinib in previously treated Waldenström's macroglobulinemia.

Prognostic markers and criteria to initiate therapy in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia

Diagnosis and management of Waldenstrom's macroglobulinemia

The Akt pathway regulates survival and homing in Waldenstrom macroglobulinemia

Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial

Allogeneic stem-cell transplantation in patients with Waldenström macroglobulinemia: report from the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation

P304

252-262

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CLML.2017.02.028

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Faiz Anwer

P577

2017-03-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28366781

http://www.w3.org/2001/XMLSchema#string

P921

pathogenesis

P932

5413391

http://www.w3.org/2001/XMLSchema#string

Waldenström Macroglobulinemia: Review of Pathogenesis and Management.

about

P2860

P2860

Waldenström Macroglobulinemia: Review of Pathogenesis and Management.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932